Judith E Karp

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Dna Damage Response

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Hochman, Megan K D Othus, Robert P Hasserjian, Alexander J Ambinder, Andrew Brunner, Mary-Elizabeth M Percival, Christopher S Hourigan, Ronan Swords, Amy E DeZern, Elihu H Estey, Judith E Karp
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification. Leukemia (2023)
Paul H Frankel, Susan Groshen, Jan H Beumer, Laura Cleveland, Edward S Kim, Judith E Karp
Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Paul H Frankel, Susan Groshen, Jan H Beumer, Laura Cleveland, Edward S Kim, Judith E Karp
Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Husheng Ding, Nicole D Vincelette, Cordelia D McGehee, Mira A Kohorst, Brian D Koh, Annapoorna Venkatachalam, X Wei Meng, Paula A Schneider, Karen S Flatten, Kevin L Peterson, Cristina Correia, Sun-Hee Lee, Mrinal Patnaik, Jonathan A Webster, Gabriel Ghiaur, B Douglas Smith, Judith E Karp, Keith W Pratz, Hu Li, Larry M Karnitz, Scott H Kaufmann
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia. Cancer research 81 (10) (2021)